IPO registrations (S-1, F-1) · Registrants
CORIXA CORP
- SEC CIK
- 1042561 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1997-07-25, last 1997-09-30; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 1997-10-02; withdrawal requested 1997-09-19
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 1900 9TH AVENUE, SUITE 1100, Seattle, WA 98101
- EIN
- 91-1654387
- EDGAR entity type
- operating
Offering terms
- Final price
- $13.00 per share (424B4 filed 1997-10-02, an initial public offering)
- Shares sold
- 3,000,000
- Gross proceeds
- $39,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CRXA
- Lead underwriters
- Lehman Brothers (772,000 shares)
- Syndicate
- Invemed Associates, Inc (586,000); Vector Securities International, Inc (586,000); Credit Suisse (76,000); Deutsche Bank (76,000); Hambrecht & Quist (76,000); Merrill Lynch (76,000); Montgomery Securities (76,000); J.P. Morgan (76,000); Oppenheimer (76,000); Prudential Securities (76,000); SBC Warburg Dillon Read Inc (76,000); UBS (76,000); Ragen MacKenzie Incorporated (76,000); Cowen (44,000); Genesis Merchant Group Securities LLC (44,000); Needham & Company (44,000); Raymond James (44,000); Sands Brothers Co., Ltd (44,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1997-07-25 | S-1 | S-1 (registration) | CORIXA CORP | 0000891020-97-000996 ↗ |
| 1997-08-29 | S-1/A | S-1/A (amendment) | CORIXA CORP | 0000891020-97-001199 ↗ |
| 1997-09-19 | RW | RW (withdrawal request) | CORIXA CORP | 0000891020-97-001234 ↗ |
| 1997-09-19 | S-1/A | S-1/A (amendment) | CORIXA CORP | 0000891020-97-001236 ↗ |
| 1997-09-26 | S-1/A | S-1/A (amendment) | CORIXA CORP | 0000891020-97-001260 ↗ |
| 1997-09-30 | S-1/A | S-1/A (amendment) | CORIXA CORP | 0000891020-97-001274 ↗ |
| 1997-09-30 | S-1/A | S-1/A (amendment) | CORIXA CORP | 0000891020-97-001277 ↗ |
| 1997-10-02 | S-1MEF | S-1MEF (added securities) | CORIXA CORP | 0000891020-97-001284 ↗ |
| 1997-10-02 | 424B4 | 424B4 (final prospectus) | CORIXA CORP | 0000891020-97-001287 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1997-09-30 | S-1/A | registration statement | $0.02 | - | - | 0 | from the submission text; price line | document ↗ | ||
| 1997-10-02 | 424B4 | final prospectus | $13.00 | 3,000,000 | $39,000,000 | Nasdaq CRXA | 19 | from the submission text; price sentence, shares headline, proceeds computed, underwriting table 19, cover names 3 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), WA first:
- Seagen Inc. WA
- ZYMOGENETICS INC WA
- NS Wind Down Co., Inc. WA
- Adaptive Biotechnologies Corp WA
- Juno Therapeutics, Inc. WA
- LeonaBio, Inc. WA
- Sana Biotechnology, Inc. WA
- Icosavax, Inc. WA
- Intrinsic Medicine, Inc. WA
- Aurion Biotech, Inc. WA
In other datasets, the same topic (Health) in WA:
- Nonprofit: ACUPUNCTURE RELIEF PROJECT (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health